Transmission from the Oropharynx to the Urethra among Men who have Sex with Men

Similar documents
CHARLOTTE K. KENT, MPH,* JANICE K. CHAW, MPH,* ROBERT P. KOHN, MPH,* YING Q. CHEN, PHD, AND JEFFREY D. KLAUSNER MD, MPH*

Original Study. Culture of Non-Genital Sites Increases the Detection of Gonorrhea in Women

Extragenital Chlamydia and Gonorrhea. Angel Stachnik, MPH Sr. Epidemiologist Office of Epidemiology and Disease Surveillance

Trends in Reportable Sexually Transmitted Diseases in the United States, 2007

Answers to those burning questions -

The objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and

Suboptimal Adherence to Repeat Testing Recommendations for Men and Women With Positive Chlamydia Tests in the United States,

Screening & Treating Chlamydia in Primary Care. Wednesday, September 21, 2016

Chlamydia trachomatis and Neisseria gonorrhoeae are the

Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham

Index. Infect Dis Clin N Am 19 (2005) Note: Page numbers of article titles are in boldface type.

Factors associated with repeat symptomatic gonorrhea infections among men who have sex with men, Bangkok, Thailand

Communicable Diseases

Clinical settings and specialities notifying cases of bacterial sexually transmitted infections in Switzerland

Abstract. Peters et al. BMC Infectious Diseases 2011, 11:203

Sinan B. Issa, Dept. of Microbiology, College of Medicine, Tikrit University

Rate and Predictors of Repeat Chlamydia trachomatis Infection Among Men

CHLAMYDIA/GC AMPLIFIED RNA ASSAY

NIH Public Access Author Manuscript Sex Transm Infect. Author manuscript; available in PMC 2013 June 04.

T here are an estimated cases of gonorrhoea annually

Forsyth County, North Carolina 2012 HIV/STD Surveillance Report


5/1/2017. Sexually Transmitted Diseases Burning Questions

Running head: EXAMINING THE ASSOCIATION BETWEEN SELF-REPORTED GONORRHEA AND BEHAVIORAL DETERMINANTS AMONG ADOLESCENT WOMEN

Incidence and Treatment Outcomes of Pharyngeal. Infections in Men Who Have Sex with Men: A 13-Year Retrospective Cohort Study

Sexually Transmi/ed Diseases

Practice Steps for Implementation of Guidelines Recommendations The guideline recommendations are shown schematically -

Evaluation of CDC-Recommended Approaches for Confirmatory Testing of Positive Neisseria gonorrhoeae Nucleic Acid Amplification Test Results

The cost-effectiveness of screening men who have sex with men for rectal chlamydial and

Forsyth County, North Carolina 2013 HIV/STD Surveillance Report

4. Chlamydia. Treatment: Treating infected patients prevents further transmission to sex partners. In addition, treatment of chlamydia in pregnant

Women s Sexual Health: STI and HIV Screening. Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins

Nucleic Acid Amplification Tests for Diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis Rectal Infections

The epidemiology of Chlamydia trachomatis infection. Chlamydia trachomatis Infection in Asymptomatic Men. Background

Dual Therapy: Symptoms and Screening:

Sexually Transmitted Infections In Manitoba

Unprotected sex in an STD clinic population: Agreement between self-reported condom use and PCR detection of y-chromosome in vaginal fluid

Patient-Delivered Partner Treatment for Male Urethritis: A Randomized, Controlled Trial

Extragenital Gonorrhea and Chlamydia among MSM

HIV Testing Among Patients Infected with Neisseria gonorrhoeae: STD Surveillance Network, United States,

GAY MEN/MSM AND STD S IN NJ: TAKE BETTER CARE OF YOUR PATIENTS! STEVEN DUNAGAN SPECIAL PROJECTS COORDINATOR NJ DOH STD PROGRAM SEPTEMBER 27, 2016

Notifiable Sexually Transmitted Infections 2009 Annual Report

CHAPTER 1: SEXUALLY TRANSMITTED AND BLOODBORNE INFECTIONS

Ten Years of Surveillance Data. B. Denise Stokich. A Master s Paper submitted to the faculty of. the University of North Carolina at Chapel Hill

Infection with Chlamydia trachomatis is

Screening for Gonorrhea: Recommendation Statement

Sexual behavior survey and screening for chlamydia and gonorrhea in university students in South Korea

STD Essentials for the Busy Clinician. Stephanie E. Cohen, MD, MPH

Services for GLBTQ Youth

Khalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine. April 2, 2014

Sexually transmitted diseases (STDs) at extragenital sites are

Extra-genital STIs: An update. Luis F. Barroso, M.D. Associate Professor Wake Forest Baptist Health

Management of Gonorrhea in Adolescents and Adults in the United States

Clinical Education Initiative TITLE: UPDATE ON MSM SEXUAL HEALTH. Speaker: Maureen Scahill, MS NP

Sexually Transmitted Diseases. Chlamydial. infection. Questions and Answers

Clinical Practice Objectives

6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?

17a. Sexually Transmitted Diseases and AIDS. BIOLOGY OF HUMANS Concepts, Applications, and Issues. Judith Goodenough Betty McGuire

STI Indicators by STI

Sexually Transmitted Diseases This publication was made possible by Grant Number TP1AH from the Department of Health and Human Services,

Yolo County Chlamydia and Gonorrhea Trends,

Received 26 November 2003/Returned for modification 6 January 2004/Accepted 6 April 2004

How is it transferred?

Expedited Partner Therapy (EPT)/Patient Deliver Partner Therapy (PDPT)

Duration of Persistence of Gonococcal DNA Detected by Ligase Chain Reaction in Men and Women following Recommended Therapy for Uncomplicated Gonorrhea

Sexually Transmitted Infection surveillance in Northern Ireland An analysis of data for the calendar year 2011

STDs in Women and Infants

Sexually Transmitted Infections. Kim Dawson October 2010

STD Prevention Among Youth

Sexually Transmitted Diseases

STDs among Men who Have Sex with Men (MSM), San Francisco

Biology 3201 Unit 2 Reproduction: Sexually Transmitted Infections (STD s/sti s)

CDC Laboratory Update

Title: Public Health Reporting and National Notification for Gonorrhea

2014 CDC GUIDELINES CHLAMYDIA & GONORRHEA DIAGNOSTICS. Barbara Van Der Pol, PhD, MPH University of Alabama at Birmingham

Family Planning Title X Chlamydia Screening Quality Improvement Project

Chlamydia Trachomatis and Neisseria Gonorrhoeae. Khalil G. Ghanem, MD Johns Hopkins University

Rectal Gonorrhea and Chlamydia Reinfection Is Associated With Increased Risk of HIV Seroconversion

Receptive Anal Intercourse and HIV Infection

CHLAMYDIA TRACHOMATIS IN CANADA: AN UPDATE

Gonorrhea. Epidemiology in the United States. Epidemiology by Demographics. This is a PDF version of the following document:

ACKNOWLEDGEMENTS FOR FURTHER INFORMATION

Trends in STDs: US Perspective. Michael Towns, M.D. WW Vice President, Medical Affairs BD Diagnostic Systems

Study on asymptomatic Neisseria gonorrhoeae cases among infertile subjects

GONORRHEA; ACUTE Does Not Include Chronic Gonorrhea

Chlamydia - CDC Fact Sheet (Detailed)

Circumcision and STD in the United States: cross sectional and cohort analyses

Sexual relationships, risk behaviour, and condom

SYNDROMIC CASE MANAGEMENT OF STD

Azithromycin for Rectal Chlamydia: Is it Time to Leave Azithromycin on the Shelf?...Not Yet. Jordan, Stephen J. MD, PhD; Geisler, William M.

CDC Grand Rounds: The Growing Threat of Multidrug-

Global incidence and prevalence of selected curable sexually transmitted infections 2008

Guidelines for the Laboratory Detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Treponema pallidum Testing

Sexually Transmitted Infection Treatment and HIV Prevention

City and County of Denver Sexually Transmitted Infections Surveillance Report 2005

10. Communicable Diseases

OBJECTIVES. Emerging Laboratory Diagnostic Options for Sexually-transmitted Infections

Sexual Health, HIV, and STDs

Effect of Endocervical Specimen Adequacy for Detection of ACCEPTED. Wyoming Public Health Laboratory, 517 Hathaway Bldg., 2300 Capitol Ave.

Emerging Laboratory Diagnostic Options for Sexually-transmitted Infections

Transcription:

MAJOR ARTICLE Chlamydia trachomatis and Neisseria gonorrhoeae Transmission from the Oropharynx to the Urethra among Men who have Sex with Men Kyle T. Bernstein, 1 Sally C. Stephens, 1 Pennan M. Barry, 1,3 Robert Kohn, 1 Susan S. Philip, 1 Sally Liska, 2 and Jeffrey D. Klausner 1,3 1 STD Prevention and Control Services and 2 Public Health Laboratory, San Francisco Department of Public Health, and 3 University of California, San Francisco, San Francisco, California (See the editorial commentary by Weinstock and Workowski on pages XXX XX) Background. Limited data exist on the risk of Chlamydia trachomatis and Neisseria gonorrhoeae transmission from oropharynx to urethra. We examined urethral C. trachomatis and N. gonorrhoeae positivity among men who have sex with men (MSM) seen at San Francisco City Clinic (San Francisco, CA) during 2007. Methods. All patients who sought care at the San Francisco City Clinic (the only municipal sexually transmitted disease clinic in San Francisco) received a standardized interview conducted by clinicians. We estimated urethral C. trachomatis and N. gonorrhoeae positivity for 2 groups of visits by MSM who visited during 2007: (1) men who reported their only urethral exposure was receiving fellatio in the previous 3 months and (2) men who reported unprotected insertive anal sex in the previous 3 months. Additionally, urethral C. trachomatis and N. gonorrhoeae positivity was estimated, stratified by human immunodeficiency virus infection status, urogenital symptom history, and whether the patient had been a contact to a sex partner with either chlamydia or gonorrhea. Results. Among MSM who reported only receiving fellatio, urethral C. trachomatis and N. gonorrhoeae positivity were 4.8% and 4.1%, respectively. These positivity estimates were similar to positivity found among MSM who reported unprotected insertive anal sex. Conclusions. A more complete understanding of the risks of transmission of C. trachomatis and N. gonorrhoeae from oropharynx to urethra will help inform prevention and screening programs. Chlamydia trachomatis and Neisseria gonorrhoeae infections are the 2 most commonly reported notifiable conditions in the United States [1]. In 2007, over 1 million cases of chlamydia and nearly 360,000 cases of gonorrhea were reported to the Centers for Disease Control and Prevention [1]. Untreated C. trachomatis and N. gonorrhoeae infections are associated with infertility, pelvic inflammatory disease, and ectopic pregnancy in women and epididymitis, prostatitis, and infertility in men [2, 3]. Furthermore, chlamydia and Received 20 May 2009; accepted 5 August 2009; electronically published 13 November 2009. Reprints or correspondence: Dr Kyle Bernstein, San Francisco Dept of Public Health, STD Prevention and Control, 1360 Mission St, Ste 401, San Francisco, CA 94102 (kyle.bernstein@sfdph.org). Clinical Infectious Diseases 2009; 49:000 000 2009 by the Infectious Diseases Society of America. All rights reserved. 1058-4838/2009/4912-00XX$15.00 DOI: 10.1086/648427 gonorrhea have been associated with increased risk of transmission and acquisition of human immunodeficiency virus (HIV) infection [4]. It is well established that C. trachomatis and N. gonorrhoeae can be transmitted through unprotected vaginal and anal sex and from the male urethra to the oropharynx through oral sex [2, 3, 5]. However, sparse data exist on the risk of transmission from the oropharynx to male urethra during fellatio. Case series have suggested the oropharynx might be an important reservoir for transmission [6, 7]. In a French clinic-based sample, 58% of men who have sex with men (MSM) with urethral gonorrhea reported that their only exposure was receiving fellatio [8]. A study by Lafferty et al [5] reported that a quarter of men with urethral gonorrhea reported receptive fellatio as the sole sexual exposure. These earlier reports were limited by unavailability of nucleic acid amplification testing for gonorrhea, which is a diagnostic technology with signifi- Urethral Chlamydia and Gonorrhea from Fellatio CID 2009:49 (15 December) 000

cantly improved sensitivity, compared with culture [9, 10]. Furthermore, no studies have studied potential oropharynx-tourethral transmission of C. trachomatis. Here, we examined urethral chlamydial and gonococcal infections among MSM to estimate the probabilities of urethral infection that likely resulted from transmission from the oropharynx to the urethra. C. trachomatis and N. gonorrhoeae positivity was estimated among visits by MSM in which the only reported urethral exposure was receiving oral sex. In order to place these data in proper context, we also estimated urethral C. trachomatis and N. gonorrhoeae positivity among MSM visits in which patients reported unprotected insertive anal sex, which is behavior considered involve a high risk for urethral infection [2, 3]. PATIENTS AND METHODS We examined urethral C. trachomatis and N. gonorrhoeae positivity among 2 groups of visits by MSM at San Francisco City Clinic (San Francisco, CA; the only municipal sexually transmitted disease [STD] clinic in San Francisco) during 2007. The first group (receiving fellatio only) was restricted to visits by MSM in which the patient reported receiving fellatio and denied vaginal sex and anal sex in the previous 3 months. The second group (unprotected insertive anal sex) was restricted to visits by MSM in which the patient reported unprotected insertive anal sex and denied vaginal sex in the previous 3 months. This second group did not exclude visits by MSM in which receptive fellatio was reported. Visits by MSM that did not include a test for either urethral gonorrhea or urethral chlamydia were excluded from the analysis. As part of the San Francisco STD clinic visit, clinicians conducted a standardized interview with the patient, which included the reason(s) for the visit and any symptoms, as well as sexual and drug use risk behaviors in the preceding 3 months. All data were recorded on paper forms and entered into an electronic database. MSM provided urine specimens, which were tested for C. trachomatis and/or N. gonorrhoeae using transcription-mediated amplification (Gen-Probe APTIMA Combo 2; Gen Probe). We estimated urethral positivity for C. trachomatis and N. gonorrhoeae, as well as corresponding 95% confidence limits assuming a binomial distribution [11], separately for MSM visits in the 2 groups. Additionally, we estimated C. trachomatis and N. gonorrhoeae positivity stratified by the presence or absence of urethral symptoms (ie, dysuria or discharge), HIV infection status, and whether the patient was exposed to a partner with chlamydia or gonorrhea (based on patient selfreport). Pearson s x 2 statistics were used in group comparisons. Because these data were de-identified and undergoing retrospective analysis, this study was considered exempt from human subjects considerations in accordance with the Code of Federal Regulations, Title 45. RESULTS In 2007, there were 5715 visits by MSM to the San Francisco City Clinic that included a urine test for either C. trachomatis or N. gonorrhoeae. Of these visits, 397 (7.0%) were among MSM who reported that their only penile sexual contact in the past 3 months was receiving fellatio, and 1129 (19.8%) were among MSM who reported unprotected insertive anal sex in the previous 3 months. Among the 397 visits by MSM in which the patient reported receiving fellatio only, 393 (99.0%) reported not using a condom. Urethral chlamydia positivity is shown in Table 1 and Figure 1. Among the 397 visits by MSM in which receiving fellatio was the only reported urethral exposure, 19 (4.8%; 95% confidence interval [CI], 2.9% 7.4%) had a urethral chlamydial infection. Urethral chlamydia positivity for visits in which only receiving fellatio was reported was not statistically significantly lower than visits in which any unprotected insertive anal sex was reported (Figure 1). Urethral chlamydia positivity for visits by MSM in which the patient reported only receiving fellatio did not differ with respect to urethritis symptoms or having a male partner with chlamydia. However, visits by HIV-infected MSM in which patients reported only receiving fellatio had higher urethral chlamydia positivity, compared with that for visits by HIV-negative MSM in which only receptive fellatio was reported (16.0% vs 3.0%; P!.001, by x 2 test) (Table 1). Urethral gonorrhea positivity results are also shown in Table 1 and Figure 1. Among the 395 visits by MSM who reported only receiving fellatio during the previous 3 months and who were tested for gonorrhea, urethral N. gonorrhoeae infection was identified in 16 (4.1%; 95% CI, 2.3% 6.5%). Urethral gonorrhea among visits by MSM in which only receiving fellatio was reported was significantly lower than urethral N. gonorrhoeae among MSM reporting unprotected insertive anal sex ( P p.018, by x 2 test) (Figure 1). Urethral gonorrhea positivity was significantly higher for visits by MSM with urethral symptoms who reported only receiving fellatio, compared with that for visits by asymptomatic MSM in which only receiving fellatio was reported (13.1% vs 0.7%; P!.001, by x 2 test). For visits by MSM in which only receiving fellatio was reported, no differences in gonorrhea positivity were found with respect to having contact with a partner with gonorrhea. However, urethral positivity among visits by MSM in which the only sexual exposure was receiving fellatio differed by HIV infection status. Additionally, we examined the self-reported behaviors of the 314 MSM with urethral C. trachomatis and 292 MSM with urethral N. gonorrhoeae infections diagnosed at San Francisco City Clinic in 2007. Sixteen (5.1%) and 19 (6.5%) of the urethral C. trachomatis and N. gonorrhoeae infections diagnosed 000 CID 2009:49 (15 December) Bernstein et al

Table 1. Urethral Chlamydia trachomatis and Neisseria gonorrhoeae Positivity among Men Who Have Sex with Men (MSM) Who Visited the San Francisco City Clinic, 2007 Variable No. of MSM tested No. of MSM with positive results Percentage of MSM positive (95% confidence interval) P Chlamydia trachomatis Only received fellatio in prior 3 Months 397 19 4.8 (2.9 7.4) Yes 107 9 8.4 (3.9 15.4).060 No 290 10 3.5 (1.7 6.3) Contact to a partner with chlamydia Yes 43 4 9.3 (2.6 22.1).138 No 354 15 4.2 (2.4 6.9) HIV infected 50 8 16.0 (7.2 29.1)!.001 HIV uninfected 335 10 3.0 (1.4 5.4) HIV infection status unknown 12 1 8.3 (0.2 38.5) Unprotected insertive anal sex in prior 3 months 1129 79 7.0 (5.6 8.6) Yes 289 53 18.3 (14.1 23.3)!.001 No 840 26 3.1 (2.0 4.5) Contact to a partner with chlamydia Yes 191 8 4.2 (1.8 8.1).039 No 938 82 7.6 (6.0 9.5) HIV infected 372 27 7.3 (4.8 10.4).698 HIV uninfected 748 52 7.0 (5.2 9.0) HIV infection status unknown 9 0 0.0 (0.0 33.6) Neisseria gonorrhoeae Only received fellatio in prior 3 months 395 16 4.1 (2.3 6.5) Yes 107 14 13.1 (7.3 21.0)!.001 No 288 2 0.7 (0.1 2.5) Contact to a partner with gonorrhea Yes 42 0 0.0 (0.0 8.4).395 No 353 16 4.5 (2.6 7.2) HIV infected 50 5 10.0 (3.3 21.8).044 HIV uninfected 334 10 3.0 (1.4 5.4) HIV infection status unknown 11 1 9.1 (0.2 41.3) Unprotected insertive anal sex in prior 3 months 1121 84 7.5 (6.0 9.2) Yes 282 74 26.2 (21.2 31.8)!.001 No 839 10 1.1 (0.6 2.2) Contact to a partner with gonorrhea Yes 189 9 4.8 (2.2 8.9).131 No 932 75 8.1 (6.4 10.0) HIV infected 370 41 11.1 (8.1 14.7).005 HIV uninfected 742 42 5.7 (4.1 7.6) HIV infection status unknown 9 1 11.1 (0.3 48.3) NOTE. HIV, human immunodeficiency virus.

Figure 1. Chlamydia trachomatis and Neisseria gonorrhoeae positivity among men who have sex with men who visited the San Francisco City Clinic, 2007. at the STD clinic were among MSM who reported receptive oral sex as their only urethral exposure. DISCUSSION Transmission of both C. trachomatis and N. gonorrhoeae from the male urethra to the oropharynx has been well described, [2, 3]; however, little data exist regarding transmission from the oropharynx to the urethra. Several case series exist [6, 8, 12], yet we know of only 1 epidemiologic study that has examined transmission from the oropharynx to the male urethra. That study was limited to N. gonorrhoeae, and diagnosis was based on culture, which is a technique that has limited sensitivity for gonococcal infection, compared with nucleic acid amplification testing [5]. Among visits by MSM in which the only reported urethral exposure was receiving oral sex, the positivity of urethral C. trachomatis and N. gonorrhoeae was 4.8% and 4.1%, respectively. The finding that urethral chlamydia positivity was not statistically different for visits by MSM in which patients reported only receiving fellatio, compared with those who reported unprotected insertive anal sex, further suggests that this mode of transmission might be more important than previously considered. Limited data regarding urethral chlamydial and gonococcal infections contracted through oral sex might have led to the assumption that oral-genital transmission of these bacteria are relatively unimportant. Among the 314 and 292 urethral C. trachomatis and N. gonorrhoeae infections diagnosed among MSM at San Francisco City Clinic in 2007, 16 (5.1%) and 19 (6.5%), respectively, were among men who reported receiving fellatio in the prior 3 months as their only urethral exposure. These data are restricted to visits by MSM in which the only source of urethral exposure was through receiving fellatio, likely making this an underestimate of the proportion of chlamydial and gonococcal infections potentially acquired though oral sex. Additional urethral C. trachomatis and N. gonorrhoeae infections among MSM who reported other urethral exposures, such as vaginal or insertive anal sex, in addition to oral sex, might have occurred as a result of fellatio. Oral sex is a common practice among MSM [13, 14]. Recently collected data from a venue-based sample of MSM in San Francisco found that 180% reported receiving fellatio (H. Fisher Raymond, personal communication). As a result, urethral C. trachomatis and N. gonorrhoeae infections that result from fellatio might be an important and underappreciated mode of transmission. Additional studies that take advantage of sampling multiple anatomic sites with highly sensitive nucleic acid amplification tests might help to elucidate the potential public health impact of urethral gonorrhea and chlamydia acquired through oral sex. Among visits by MSM in which patients reported only receiving fellatio, we found a higher urethral positivity for both C. trachomatis and N. gonorrhoeae among HIV-infected MSM, compared with MSM who were either HIV-uninfected or whose HIV infection status was unknown. This finding likely is more a result of sexual practices than of biological factors associated with HIV infection. Among visits by MSM in our analysis who reported only receiving fellatio, HIV-infected MSM reported more male sex partners in the previous 3 months than did HIV-uninfected MSM (HIV-infected: mean no. of partners, 7.54; median no. of partners, 4; HIV uninfected: mean no. of partners, 5.90; median no. of partners, 3). Therefore, the higher prevalence of urethral positivity among visits by HIV-infected 000 CID 2009:49 (15 December) Bernstein et al

MSM might have resulted from increased sexual activity and, in turn, increased exposure to infected partners. Our analysis has several limitations. Data were collected from MSM seeking care at the San Francisco STD clinic. As a result, these patients might not be representative of all MSM in San Francisco or other localities. Additionally, this analysis was cross-sectional and relied on self-reported sexual behavior in the 3 months prior to the clinic visit. It is possible that social desirability might have led some MSM to underreport unprotected anal sex, which might have been different between men with and men without urethral disease, especially among those men with urethral symptoms. However, when we limited analyses to visits by MSM in which the patient was asymptomatic when tested, the positivity of urethral C. trachomatis and N. gonorrhoeae was still statistically greater than zero, and no differences in positivity were seen between those reporting unprotected insertive anal sex and those reporting receiving fellatio only. We did not restrict this analysis to visits by MSM in which fellatio without condom use was reported. However, nearly all of the MSM in our analysis who reported receiving fellatio only did not use a condom. Additionally, the misclassification of some MSM as having only unprotected fellatio, when in fact that exposure was protected, would render our estimates as conservative, because it is unlikely that these men would get a urethral infection, yet would contribute to the calculation of positivity. Finally, it is possible that the urethral infections identified represent infections that were the result of exposures that occurred before the 3-month recall period. However, when we limited the analysis to patients who presented with urethritis, which likely represents recent infection, positivity increased among all groups. However, the results of the comparisons of positivity for C. trachomatis and N. gonorrhoeae between MSM visits in which only receptive fellatio and unprotected insertive anal sex were reported were similar to the crude analysis. Among an STD clinic based sample, we demonstrated that the transmission of C. trachomatis and N. gonorrhoeae from the oropharynx to the urethra is prevalent and might represent a mode of transmission important to the continual populationlevel spread of disease. Patients should be encouraged to be screened regularly for STDs at exposed anatomic sites if they are sexually active and should be reminded that urethral infections can be acquired through oral sex. Acknowledgments Potential conflicts of interest. J.D.K. has received research or educational support from Gen-Probe, Focus Technologies, and King Pharmaceuticals. P.M.B. has received research support from Forest Laboratories. J.D.K. has received research support from Forest Laboratories. All other authors: no conflicts. Financial support. US Public Health Service T32 (grant AI007641-06A2), the Peninsula AIDS Research Center funded by California HIV Research Program (grant CH05-SMCHC-612), Comprehensive STD Prevention Projects (1H25PS001354-01) of the Centers for Disease Control and Prevention, and a Council of State and Territorial Epidemiologists/ Centers for Disease Control and Prevention Applied Epidemiology Fellowship (to S.S.). References 1. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2007. Atlanta, GA: US Department of Health and Human Services, 2008. 2. Stamm WE. Chlamydia trachomatis infections in the adult. In: Holmes KK, Sparling PF, Stamm WE, et al., eds. Sexually transmitted diseases. 4th ed. New York: McGraw Hill, 2008. 3. Hook EW 3rd, Handsfield HH. Gonococcal infections in the adult. In: Holmes KK, Sparling PF, Stamm WE, et al., eds. Sexually transmitted diseases. 4th ed. New York: McGraw Hill, 2008. 4. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3 17. 5. Lafferty WE, Hughes JP, Handsfield HH. Sexually transmitted diseases in men who have sex with men: acquisition of gonorrhea and nongonococcal urethritis by fellatio and implications for STD/HIV prevention. Sex Transm Dis 1997; 24:272 8. 6. Soendjojo A. Gonococcal urethritis due to fellatio. Sex Transm Dis 1983; 10:41 2. 7. Tice AW Jr, Rodriguez VL. Pharyngeal gonorrhea. JAMA 1981;246: 2717 9. 8. Janier M, Lassau F, Casin I, Morel P. Pharyngeal gonorrhoea: the forgotten reservoir. Sex Transm Infect 2003; 79:345. 9. Johnson RE, Newhall WJ, Papp JR, et al. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections 2002. MMWR Recomm Rep 2002; 51(RR-15):1 38. 10. Cook RL, Hutchison SL, Ostergaard L, Braithwaite RS, Ness RB. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005; 142:914 25. 11. Szklo M, Nieto FJ. Epidemiology beyond the basics. Gaithersburg, MD: Aspen Publishers, 2000. 12. David LM. Acquisition of pharyngeal gonorrhoea via sweets passed by mouth. Genitourin Med 1997; 73:146. 13. Katz MH, McFarland W, Guillin V, et al. Continuing high prevalence of HIV and risk behaviors among young men who have sex with men: the young men s survey in the San Francisco Bay Area in 1992 to 1993 and in 1994 to 1995. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:178 81. 14. Schwarcz SK, Kellogg TA, McFarland W, et al. Characterization of sexually transmitted disease clinic patients with recent human immunodeficiency virus infection. J Infect Dis 2002; 186:1019 22. Urethral Chlamydia and Gonorrhea from Fellatio CID 2009:49 (15 December) 000